Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer
出版年份 2016 全文链接
标题
Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer
作者
关键词
Immune expression signatures, Co-expression modules, Immune subtypes, Breast cancer
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 161, Issue 1, Pages 41-50
出版商
Springer Nature
发表日期
2016-11-04
DOI
10.1007/s10549-016-4041-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Improved Survival of HER2+Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular Domain
- (2016) Keith L. Knutson et al. CANCER RESEARCH
- Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
- (2016) Lucia Festino et al. DRUGS
- The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis
- (2016) Pedro N Aguiar et al. Immunotherapy
- Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
- (2016) Nayoung Lee et al. PATHOLOGY
- Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade
- (2016) P.-L. Chen et al. Cancer Discovery
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- Targeted T-cell Therapy in Stage IV Breast Cancer: A Phase I Clinical Trial
- (2015) L. G. Lum et al. CLINICAL CANCER RESEARCH
- Tumor-Infiltrating Lymphocytes and Response to Neoadjuvant Chemotherapy With or Without Carboplatin in Human Epidermal Growth Factor Receptor 2–Positive and Triple-Negative Primary Breast Cancers
- (2015) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Immunotherapy for the Treatment of Breast Cancer
- (2015) Brenda Ernst et al. Current Oncology Reports
- Trastuzumab upregulates expression of HLA-ABC and T cell costimulatory molecules through engagement of natural killer cells and stimulation of IFNγ secretion
- (2015) Bharat K. R. Chaganty et al. OncoImmunology
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Adoptive cellular immunotherapy for the treatment of patients with breast cancer: A meta-analysis
- (2014) Zheng-Xu Wang et al. CYTOTHERAPY
- Gene Co-Expression Modules as Clinically Relevant Hallmarks of Breast Cancer Diversity
- (2014) Denise M. Wolf et al. PLoS One
- Immunotherapeutics for breast cancer
- (2013) Carmen Criscitiello et al. CURRENT OPINION IN ONCOLOGY
- Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
- (2013) Gabriela Bindea et al. IMMUNITY
- The Prognostic Implications of Macrophages Expressing Proliferating Cell Nuclear Antigen in Breast Cancer Depend on Immune Context
- (2013) Michael J. Campbell et al. PLoS One
- Tumor-infiltrating lymphocytes, breast cancer subtypes and therapeutic efficacy
- (2013) Sherene Loi OncoImmunology
- Immunomodulation via Chemotherapy and Targeted Therapy: A New Paradigm in Breast Cancer Therapy?
- (2012) John Stagg et al. Breast Care
- Breast cancer immunobiology driving immunotherapy: vaccines and immune checkpoint blockade
- (2012) Leisha A Emens Expert Review of Anticancer Therapy
- Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures
- (2011) Cheng Fan et al. BMC Medical Genomics
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
- (2011) David G. DeNardo et al. Cancer Discovery
- Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules
- (2010) Andrew E Teschendorff et al. BMC CANCER
- Clinical Studies With Anti–CTLA-4 Antibodies in Non-melanoma Indications
- (2010) Luana Calabrò et al. SEMINARS IN ONCOLOGY
- Therapeutic Breast Cancer Vaccines
- (2009) Nathan M. Shumway et al. BIODRUGS
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- An Immune Response Enriched 72-Gene Prognostic Profile for Early-Stage Non-Small-Cell Lung Cancer
- (2008) P. Roepman et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search